The small molecule compound THTMP regulates the activity of Bcl‐2 family proteins through the p53 signaling pathway, inhibits antiapoptotic genes, and triggers G1/S phase cell cycle stasis and programed cell death in GBM cells [16]. The gene discussed is BCL2; the disease is glioblastoma.